Advertisement

Cardiac Infections in the Pediatric Intensive Care Unit

  • Laura M. Ibsen
  • Irving Shen
Chapter
  • 18 Downloads

Abstract

In a general pediatric intensive care unit that includes cardiac surgical patients, the most common cardiac infections encountered are postsurgical complications. Patients who are acutely ill with endocarditis, myocarditis, or pericarditis may also require intensive care. After immediate stabilization, the general principles of taking a thorough history and considering patient exposures remains paramount. An integrated team approach, involving critical care specialists, infectious disease specialists, cardiologists, and surgeons, is vital to providing excellent care for these patients.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle Scholar
  2. 2.
    Edwards MS, Backer CJ. Median sternotomy wound infections in children. Pediatr Infect Dis J 1982;2:105–109.CrossRefGoogle Scholar
  3. 3.
    Jimenez-Martinez M, Arguero-Sanchez R, Rerez-Alvarez JJ, Mina-Castaneda P. Anterior mediastinitis as a complication of median sternotomy incisions: diagnostic and surgical considerations. Surgery 1970;67:929–934.PubMedGoogle Scholar
  4. 4.
    Stiegel RM, Beasley ME, Sink JD, et al. Management of postoperative mediastinitis in infants and children by muscle flap rotation. Ann Thorac Surg 1988;46:45–46.PubMedCrossRefGoogle Scholar
  5. 5.
    Grant RT, Breitbart AS, Parnell V. Muscle flap reconstruction of pediatric poststernotomy wound infections. Ann Plast Surg 1997;38:365–370.PubMedCrossRefGoogle Scholar
  6. 6.
    Erez E, Kaatz M, Sharoni E, et al. Pectoralis major muscle flap for deep sternal wound infection in neonates. Ann Thorac Surg 2000;60:572–577.CrossRefGoogle Scholar
  7. 7.
    Pasaoglu I, Arsan S, Yorgancioglu AC, Yuksel BA. A simple management of mediastinitis. Int Surgery 1995;80:239–241.Google Scholar
  8. 8.
    Mehta PA, Cunningham CK, Colella CB, Alferis G, Weiner LB. Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J 2000;19:1000–1004.PubMedCrossRefGoogle Scholar
  9. 9.
    Huddleston CB. Mediastinal wound infections following pediatric cardiac surgery. Semin Thorac Cardiovasc Surg 2004:108–112.Google Scholar
  10. 10.
    Ruef C, Fanconi S, Nadal D. Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of Staphylococcus aureus. J Thorac Cardiovasc Surg 1996;113:681–686.CrossRefGoogle Scholar
  11. 11.
    Tabbutt S, Duncan BW, McLaughlin D, et al. Delayed sternal closure after cardiac operations in a pediatric population. J Thorac Cardiovasc Surg 1997;113:886–893.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Tortoriello TA, Friedman JD, McKenzie ED, et al. Mediastinitis after pediatric cardiac surgery: a 15-year experience at a single institution. Ann Thorac Surg 2003;76: 1655–1660.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Maher KO, VanDerElzen K, Bove EL, et al. A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients. Ann Thorac Surg 2002;74:1195–2000.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Ohye RG, Maniker RB, Graves HL, Devaney EJ, Bove EL. Primary closure for postoperative mediastinitis in children. J Thorac Cardiovasc Surg 2004;128:480–486.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Combes A, Trouillet J, Baudot J, et al. Is it possible to cure mediastinitis in patients with major postcardiac surgery complications. Ann Thorac Surg 2001;72:1592–1597.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Van Hare GF, Ben-Shachar G, Liebman J, Boxerbaum B, Riemenschneider TA. Infective endocarditis in infants and children during the past 10 years: a decade of change. Am Heart J 1984;107:1235–1240.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Martin JM, Neches WH, Wald ER. Infective endocarditis: 35 years of experience at a children’s hospital. Clin Infect Dis 1997;24:669–675.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Pediatrics 2002;109:931–943.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997;25:1448–1458.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Wells WJ. Surgical problems of endocarditis in children. J Card Surg 1989;4:313–316.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Nomura F, Penny DJ, Menahem S, Pawade A, Karl TR. Surgical intervention for infective endocarditis in infancy and childhood. Ann Thorac Surg 1995;60:90–95.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Alexiou C, Langley SM, Monro JS. Surgery for infective valve endocarditis in children. Eur J Cardiothorac Surg 1999;16:653–659.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 1998;27:1451–1456.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Millard DD, Shulman ST. The changing spectrum of neonatal endocarditis. Clin Perinatol 1988;15:587–608.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Karl TR, Wensley D, Stark J, et al. Infective endocarditis in children with congenital heart disease: comparison of selected features in patients with surgical correction or palliation and those without. Br Heart J 1987;58:57–65.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Saiman L. Endocarditis and Intravascular Infections. In: Long SS, ed. Principles and Practice of Pediatric Infectious Diseases, 2nd ed. New York: Elsevier, 2003:250–256.Google Scholar
  27. 27.
    Oelberg DG, Fisher DJ, Gross DM, Denson SE, Adcock EW 3rd. Endocarditis in high-risk neonates. Pediatrics 1983;71:392–397.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Symchych PS, Crauss AN, Winchester P. Endocarditis following intracardiac placement of umbilical venous catheters in neonates. J Pediatr 1977;90:287–289.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Pelletier LL, Petersdorf RG. Infective endocarditis. Medicine 1977;56:287–313.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: utilization of specific echocardiographic findings. Ann Intern Med 1981;94:505–518.PubMedCrossRefGoogle Scholar
  31. 31.
    Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200–209.CrossRefGoogle Scholar
  32. 32.
    Bayer AS, Ward Jl, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994;96.Google Scholar
  33. 33.
    Hoen B, Selton-Suty D, Danchin N, et al. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1995;21:905–909.PubMedCrossRefGoogle Scholar
  34. 34.
    Dodds GA, Sexton DJ, Durack DT, et al. Negative predictive value ofthe Duke criteria for infective endocarditis. Am J Cardiol 1996;77:403–407.PubMedCrossRefGoogle Scholar
  35. 35.
    Heiro M, Nikoskelainen J, Hartiala JJ, Saraste MK, Kotilainen PM. Diagnosis of infective endocarditis: sensitivity of the Duke vs von Reyn criteria. Arch Intern Med 1998;158:18–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Li J, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633–638.CrossRefGoogle Scholar
  37. 37.
    Washington JAN. The role of the microbiology laboratory in the diagnosis and antimicrobial treatment of infective endocarditis. Mayo Clin Proc 1982;57:22–32.PubMedGoogle Scholar
  38. 38.
    Towns ML, Reller LB. Diagnostic methods: current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. Infect Dis Clin North Am 2002;16:363–376.CrossRefGoogle Scholar
  39. 39.
    Everts RJ, Vinson EN, Adholla PO, Reller LB. Contamination of catheter-drawn blood cultures. J Clin Microbiol 2001;39:3393–3394.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Kavey RE, Frank DM, Byrum CJ, et al. Two-dimensional echocardiographic assessment of infective endocarditis in children. Am J Dis Child 1983;137:851–856.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Bricker JT, Latson LA, Huhta JC, Gutgesell JP. Echocardiographic evaluation of infective endocarditis in children. Clin Pediatr 1985;24:312–317.CrossRefGoogle Scholar
  42. 42.
    Karalis DA, Bansal RC, Hauck AJ, et al. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications. Circulation 1992;86:353–362.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest 2002;122:302–310.PubMedCrossRefGoogle Scholar
  44. 44.
    Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30.Google Scholar
  45. 45.
    Sanchez PJ, Seiegel JD, Fishbein J. Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J 1991;10:239–243.PubMedCrossRefGoogle Scholar
  46. 46.
    Aspesberro F, Beghetti M, Oberhansli I, Friedli B. Fungal endocarditis in critically ill children. Eur J Pediatr 1999;158:275–280.PubMedCrossRefGoogle Scholar
  47. 47.
    Minette M, Ibsen LM. Survival of candida sepsis on extracorporeal membrane oxygenation. Pediatr Crit Care Med 2005;6:709–711.PubMedCrossRefGoogle Scholar
  48. 48.
    Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936–2948.PubMedCrossRefGoogle Scholar
  49. 49.
    Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989; 14:631–638.PubMedCrossRefGoogle Scholar
  50. 50.
    Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991;18:1191–1199.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Steckelberg JM, Murphy JG, Ballar D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991;114:635–640.PubMedCrossRefGoogle Scholar
  52. 52.
    Tolan RWJ, Kleiman MB, Frank M, King H, Brown JW. Operative intervention in active endocarditis in children: report of a series of cases and review. Clin Infect Dis 1992;14:852–862.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998;26:1310–1311.CrossRefGoogle Scholar
  54. 54.
    Jaffe WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis, 1983–1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990;15:1227–1233.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Martin AB, Webber S, Fricker FJ, et al. Congenital cardiovascular disease/diabetes: acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994;90:330–339.PubMedCrossRefGoogle Scholar
  56. 56.
    Calabrese F, Rigo E, Milanesi O, et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002;11:212–221.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Garcia NS, Castelo JS, Ramos V, Rezende GS, Pereira FE. Frequency of myocarditis in cases of fatal meningococcal infection in children: observations on 31 cases studied at autopsy. Rev Soc Bras Med Trop 1999;32:517–522.PubMedCrossRefGoogle Scholar
  58. 58.
    Wasi F, Shuter J. Primary bacterial infection of the myocardium. Front Biosci 2003;8:228–231.Google Scholar
  59. 59.
    Batra AS, Lewis AB. Acute myocarditis. Curr Opin Pediatr 2001;13:234–239.PubMedCrossRefGoogle Scholar
  60. 60.
    Leonard EG. Viral myocarditis. Pediatr Infect Dis J 2004;23:665–666.PubMedCrossRefGoogle Scholar
  61. 61.
    Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000;102:2829–2835.PubMedCrossRefGoogle Scholar
  62. 62.
    Bergelson JM. Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol 1999;57:975–979.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Feldman AM, McNamara DM. Myocarditis. N Engl J Med 2000;343:1388–1398.PubMedCrossRefGoogle Scholar
  64. 64.
    Cioc AM, Nuovo GJ. Histologic and In Situ viral findings in the myocardium in cases of sudden, unexpected death. Mod Pathol 2002;15:914–922.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Dettmeyer R, Baasner A, Schlamann M, Haag C, Madea B. Coxsackie B3 myocarditis in 4 cases of suspected sudden infant death syndrome: diagnosis by immunohistochemical and molecular-pathologic investigations. Pathol Res Pract 2002; 198:689–696.PubMedCrossRefGoogle Scholar
  66. 66.
    Baasner A, Dettmeyer R, Graebe M, Rissland J, Madea B. PCR-based diagnosis of enterovirus and parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome. Lab Invest 2003;83:1451–1455.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997;30:1354–1359.PubMedCrossRefGoogle Scholar
  68. 68.
    Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualize myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802–1809.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular biology. Circulation 2004;109:1250–1258.PubMedCrossRefGoogle Scholar
  70. 70.
    Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3–14.PubMedGoogle Scholar
  71. 71.
    Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235–1245.PubMedCrossRefGoogle Scholar
  72. 72.
    Wu LA, Lapeyre AC, Cooper LT. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc 2001;76:1030–1038.PubMedCrossRefGoogle Scholar
  73. 73.
    Dec GW, Fallon JT, Southern JF, Palacios I. “Borderline” myocarditis: an indication for repeat endomyocardial biopsy. J Am Coli Cardiol 1990;15:283–289.CrossRefGoogle Scholar
  74. 74.
    Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003;60:11–25.PubMedCrossRefGoogle Scholar
  75. 75.
    Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coli Cardiol 2003;42:466–472.CrossRefGoogle Scholar
  76. 76.
    Lieberman EB, Hutchins GM, Hershkowitz A, Rose NR, Baughman KL. Clinico-pathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617–1626.PubMedCrossRefGoogle Scholar
  77. 77.
    McCarthy R, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–695.PubMedCrossRefGoogle Scholar
  78. 78.
    Nugent A W, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639–1646.PubMedCrossRefGoogle Scholar
  79. 79.
    Bohn D, Benson L. Diagnosis and management of pediatric myocarditis. Paediatr Drugs 2002;4:171–181.PubMedCrossRefGoogle Scholar
  80. 80.
    Duncan BW, Bohn D, Atz AM, et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001; 122:440–448.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Fiser WP, Yetman AT, Gunselman RJ, et al. Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. J Heart Lung Transplant 2003;22:770–777.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Tabbutt S, Leonard M, Godinez RI, et al. Severe influenza B myocarditis and myositis. Pediatr Crit Care Med 2004;5:403–406.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Cunnion RE, Parrillo JE, Maisch B, et al. Immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:1713–1714.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857–863.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Drucker NA, Colan SD, Lewis AB, et al. Congenital heart disease: gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252–257.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254–22590PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061–1068.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Mason JW, O’Connell JB, Hershkowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269–275.PubMedCrossRefGoogle Scholar
  89. 89.
    Balaji S, Wiles HB, Sens MA, Gillette PC. Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994;72:354–359.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16:61–68.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Gagliardi MG, Bevilacqua M, Bassano C, et al. Long-term follow-up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004;90:1167–1171.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004;89:580–584.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000;25:279–285.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Spodnick DH. Acute pericarditis: current concepts and practice. JAMA 2003;289:1150–1153.CrossRefGoogle Scholar
  95. 95.
    Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004;363:717–727.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Levy P, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine 2003;82:385–391.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985;56:623–630.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Launbjerg J, Fruergaard P, Hesse B, et al. Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology 1996;87:60–66.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Friman G, Pohlman J. The epidemiology of viral heart disease. Scand J Infect Dis Suppl 1993;88:7–10.PubMedPubMedCentralGoogle Scholar
  100. 100.
    Feldman WE. Bacterial etiology and mortality of purulent pericarditis in pediatric patients: a review of 162 cases. Am J Dis Child 1979;133:641–644.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Breen JF. Imaging of the pericardium. J Thorac Imaging 2001;16:47–54.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Imazio M, Demichelis B, Cecchi E, etal. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003;42:2144–2148.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Trautner BW, Darouiche RO. Tuberculous pericarditis: optimal diagnosis and management. Clin Infect Dis 2001;33:954–961.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Schifferdecker B, Spodnick DH. Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis: clinical review. Cardiology Rev 2003;11:211–217.CrossRefGoogle Scholar
  105. 105.
    Adler Y, Guindo J, Finkelstein Y, et al. Colchicine for large pericardial effusion. Clin Cardiol 1998;21:143–144.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Yazigi A, Abou-Charaf LC. Colchicine for recurrent pericarditis in children. Acta Paediatr 1998;87:603–604.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987;2(8573):1418–1422.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Strang JI, Kakaza HH, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988;2(8614):759–764.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. The Cochrane Database of Systematic Reviews 2004;4.Google Scholar
  110. 110.
    Finkelstein Y, Adler Y, Nussinovitch I, Varsano I. A new classification for pericarditis associated with meningococcal infection. Eur J Pediatr 1997;156:585–588.PubMedCrossRefGoogle Scholar
  111. 111.
    Schrank JHJ, Dooley DP. Purulent pericarditis caused by Candida species: Case report and review. Clin Infect Dis 1995;21:182–187.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2008

Authors and Affiliations

  • Laura M. Ibsen
  • Irving Shen

There are no affiliations available

Personalised recommendations

Cite chapter

Buy options